On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
After his PhD on thymocyte development at the MRC National Institute for Medical Research (NIMR) in London, Andreas Wack moved to the research institute of Novartis Vaccines in Siena, Italy, where he worked on the modulation of human T and NK cell function by the hepatitis C virus, human dendritic cell subsets and their crosstalk, the mechanism of action of vaccine adjuvants, and next generation influenza vaccines. Since 2009 he is back at the NIMR, now Francis Crick Institute, where his group studies the responses of airway epithelia and innate immune cells to influenza infection and to influenza-bacterial co-infection. His lab aims to identify determinants of immunopathology and protection and has assessed unique and redundant roles of type I and type III interferons in influenza. A second focus of his group is airway epithelial cell differentiation, a process that has to be efficient and balanced to guarantee timely repair of lung tissue damage during infection.
